Provided by Tiger Trade Technology Pte. Ltd.

Evoke Pharma

10.93
-0.0100-0.09%
Post-market: 10.930.00000.00%19:24 EST
Volume:26.31K
Turnover:287.61K
Market Cap:18.83M
PE:-5.38
High:10.94
Open:10.92
Low:10.92
Close:10.94
52wk High:10.94
52wk Low:1.94
Shares:1.72M
Float Shares:871.70K
Volume Ratio:1.99
T/O Rate:3.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.0307
EPS(LYR):-2.8094
ROE:-134.88%
ROA:-21.78%
PB:5.60
PE(LYR):-3.89

Loading ...

Nov 13, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 04, 2025

Major Issues Report

Form 8-K - Current report
Aug 14, 2025

Major Issues Report

Form 8-K - Current report
Aug 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Major Issues Report

Form 8-K - Current report
May 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2025

Major Issues Report

Form 8-K - Current report
Mar 14, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 24, 2025

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Oct 29, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]